Stock Ratings / Materials / CDXS / forecast

ACNT (40) LODE (24) AMTX (34) LTBR (41) ⌘ Pro Terminal →

Codexis Inc. (CDXS) 12-Month Stock Forecast & Price Target Cone

Q: Is CDXS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Codexis Inc. (NASDAQ: CDXS) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.22 (-3.17% 1D, market cap $133.6M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, CDXS ranks #248 in composite RQD confidence.

Q: How does CDXS compare to ACNT and LODE in the Materials sector?

Within the Materials sector (Major Chemicals), CDXS carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 86.7%, and ROIC of -35.0%. By comparison, ACNT (Ascent Industries Co.) holds a D- grade (40/100 RQD, P/E 143.4x, ROIC -18.9%, cap $124.3M) and LODE (Comstock Inc.) posts a E grade (24/100 RQD, P/E N/A, ROIC -33.3%, cap $122.3M). Among the 5-stock peer group, ACNT leads on earnings multiple (143.4x) while LTBR leads on capital efficiency (-9.1% ROIC).

Q: What are the biggest fundamental strengths and SEC risk factors for CDXS?

Per CDXS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001200375), Codexis Inc. generated $70.4M in revenue (+18.6% YoY), -$44.0M in net income, and -$23.8M in free cash flow against $147.8M in total assets and $40.1M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Q: Where is CDXS trading relative to its 50-day, 200-day, and 52-week technical levels?

CDXS last traded at $1.22 (-3.17% on volume of 917,307 shares), positioning the stock -12.86% below its 50-day simple moving average ($1.40) and -32.97% below its 200-day simple moving average ($1.82). Across its 52-week range of $0.96 to $2.98, CDXS sits at the 12.9% percentile with a 14-day RSI of 37.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.07 to $1.37).

Q: What is CDXS's 12-month stock price target?

Codexis Inc. (CDXS) carries a 12-month consensus base price target of $1.09 (-10.7% from $1.22), with a bull-case target of $3.13 and a bear-case floor of $0.85.

Q: Is CDXS stock a Buy, Hold, or Sell right now?

Roarable's 5-Pillar RQD Quant Engine rates CDXS E (Strong Sell — SELL) with an RQD Confidence score of 34/100.

$1.22 -3.17% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.21

Codexis Inc. (CDXS) carries a Roarable Rating of E (Strong Sell) with 34/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows →

ROARABLE E • RED ALERT Cap $133.6M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $1.21 (-0.76%)🧬 Dilution Drag (+2.48% YoY Shares)⚙️ Cash Engine: 5/20 (E) • 0% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record Warning: Scores below 50 (34/100 · E) historically underperformed SPY in 71% of rolling 90-day windows (-8.7% avg 90D alpha vs SPY • 29.0% hit rate).

Audit Bucket Track Record →

RQD QUANT TACHOMETERRED ALERT • E

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-10.7% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CDXS)Realized 20D OHLCV Swing Band: ±12.5%

Deterministic 5-Pillar Attribution (34/100 Composite)

🔍 WHY CDXS SCORES 34/100 (E) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Macro Regime Fit+11/20 pts (32% of score)

FRED Regime × Technicals: 13% of 52W Range • RSI-14 at 37.6 (NEUTRAL RANGE)

▲ #2 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (24% of score)

Altman Z-Score 0.20 (DISTRESS RISK (<1.8)) • Piotroski F-Score 6/9

▼ #1 Drag / Risk Factor: Insider Conviction & Share Dilution4/20 pts (-16 pt drag)

Dilution Drag (+2.48% YoY Shares) & executive Form 4 sales trim 16 pts from alignment

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade D$1.41-12.1% Next Q

Q2 (-2Q)

Grade E$1.24+3.2% Next Q

Q3 (-1Q)

Grade E$1.28-4.7% Next Q

Current

Grade E$1.22-8.7% Hist 90D α

Trajectory: D (42) → E (34)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a CDXS Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While CDXS currently carries a cautious 34/100 (E) rating due to Insider Conviction & Share Dilution (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Materials with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($1.40) and Max Pain ($1.28) forces dealer call-delta covering toward $3.13.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+2.48% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CDXS• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CDXS Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 34%NO 66%Trade / Inspect Odds →

INTERACTIVE 12-MONTH POSITION SIMULATOR

Drag to Test Your CDXS Position Size: $10,000

Shares at $1.22: 8196.7 sh

$1,000$10,000$25,000$50,000$100,000

12M Bear Case FloorTarget $0.85

$6,967

$-3,033 (-30.3%)

12M Consensus BaseTarget $1.09

$8,934

$-1,066 (-10.7%)

12M Bull Case BreakoutTarget $3.13

$25,656

+$15,656 (+156.6%)

Wall Street Analyst Breakdown & Historical Accuracy Audit (35 Desks)

Street Historical Accuracy: 64/100

● Strong Buy / Buy: 17● Hold: 9● Sell: 9

Wall Street Firm	Stance	12M Target	1Y Accuracy	Track Grade
Morgan StanleyInstitutional Equity Desk	HOLD	$1	74%	A
Goldman SachsSector Coverage Lead	UNDERPERFORM	$3	69%	B
JP MorganUS Large-Cap Research	SELL	$1	58%	C

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CDXS)

✓Walkthrough of CDXS's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CDXS // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -56.74%⚡ TESTING RESISTANCE

2026-10-30O $1.20H $1.24L $1.17C $1.22VOL 789.5K

RES: $1.27SUP: $1.19SMA50: $1.40SMA200: $1.82

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CDXS Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CDXS Butterfly Map → + Track CDXS →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +18.6% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CDXS today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CDXS. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CDXS today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CDXS)

Materials Rank #248 of 270 ⚔️ ACNT vs CDXS Full Matrix →

1. Head-to-Head Materials Peer Comparison (CDXS vs. ACNT, LODE, AMTX, LTBR)

Industry: Major Chemicals (67 Tracked Issuers)

Across 270 tracked Materials securities in the Roarable RQD universe, Codexis Inc. (CDXS) ranks #248 by composite RQD confidence (34/100, grade E) and #222 by equity capitalization ($133.6M). Within this direct 5-issuer industry benchmark cohort, ACNT leads on earnings valuation at 143.4x trailing P/E, while LTBR leads on capital efficiency and profitability with -9.1% ROIC and — gross margin. LTBR currently holds the highest overall quantitative score in the immediate peer group at 41/100 (D-) compared with CDXS at 34/100 (E).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CDXS ACTIVE Codexis Inc.	E	34/100	—	86.7%	-35.0%	-3.17%	$133.6M	Benchmark Subject
ACNT Ascent Industries Co.	D-	40/100	143.4x	23.0%	-18.9%	+1.40%	$124.3M	/acnt-vs-cdxs →
LODE Comstock Inc.	E	24/100	—	-30.0%	-33.3%	-5.85%	$122.3M	/lode-vs-cdxs →
AMTX Aemetis Inc.	E	34/100	—	-0.4%	-35.0%	-0.77%	$93.1M	/amtx-vs-cdxs →
LTBR Lightbridge Corporation	D-	41/100	—	—	-9.1%	-0.73%	$202.3M	/ltbr-vs-cdxs →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001200375

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Codexis Inc. (CDXS) reported GAAP revenue of $70.4M (+18.6% vs. FY2024 revenue of $59.3M , and +0.3% cumulative change since FY2023) , GAAP net income of -$44.0M, operating cash flow of -$19.4M, and free cash flow of -$23.8M (+55.6% YoY). On the balance sheet, CDXS closed FY2025 with $147.8M in total assets against $40.1M in total debt (Altman Z-Score: 0.20, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$70.4M	-$44.0M	-$19.4M	-$23.8M	$147.8M	$40.1M
FY2024 (FY)	2024-12-31	$59.3M	-$65.3M	-$49.4M	-$53.7M	$149.0M	$28.9M
FY2023 (FY)	2023-12-31	$70.1M	-$76.2M	-$52.6M	-$52.6M	—	—

3. CDXS Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CDXS stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Codexis Inc. (NASDAQ: CDXS) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 34/100 at a spot price of $1.22 (-3.17% 1D, market cap $133.6M). Pillar breakdown: Fundamental Cash Engine 5/20, Institutional 13F & Options Flow 7/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 11/20, and SEC Balance-Sheet Forensics 3/20. Across 270 tracked Materials issuers, CDXS ranks #248 in composite RQD confidence.

How does CDXS compare to ACNT and LODE in the Materials sector?

Within the Materials sector (Major Chemicals), CDXS carries a Roarable E (34/100 RQD), trailing P/E of N/A, gross margin of 86.7%, and ROIC of -35.0%. By comparison, ACNT (Ascent Industries Co.) holds a D- grade (40/100 RQD, P/E 143.4x, ROIC -18.9%, cap $124.3M) and LODE (Comstock Inc.) posts a E grade (24/100 RQD, P/E N/A, ROIC -33.3%, cap $122.3M). Among the 5-stock peer group, ACNT leads on earnings multiple (143.4x) while LTBR leads on capital efficiency (-9.1% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CDXS?

Per CDXS's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001200375), Codexis Inc. generated $70.4M in revenue (+18.6% YoY), -$44.0M in net income, and -$23.8M in free cash flow against $147.8M in total assets and $40.1M in total debt. Key quantitative strengths: Established market leader in Materials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CDXS trading relative to its 50-day, 200-day, and 52-week technical levels?

CDXS last traded at $1.22 (-3.17% on volume of 917,307 shares), positioning the stock -12.86% below its 50-day simple moving average ($1.40) and -32.97% below its 200-day simple moving average ($1.82). Across its 52-week range of $0.96 to $2.98, CDXS sits at the 12.9% percentile with a 14-day RSI of 37.6 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.07 to $1.37).

CDXS Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CDXS's 12-month stock price target?

Codexis Inc. (CDXS) carries a 12-month consensus base price target of $1.09 (-10.7% from $1.22), with a bull-case target of $3.13 and a bear-case floor of $0.85.